Injectable ossotide's efficacy in treating condylar fractures

Abstract

This research aimed to assess the impact of osteopeptide injections as a supplemental therapy for condylar fractures on bone glycoprotein (BGP) and interleukin-1α (IL-1в) levels as well as pain management. Two groups of eighty-two condylar neck fracture patients were randomly assigned. The experimental group received osteopeptide injections in addition to routine surgical treatments for the control group. At 1, 2, and 4 weeks after surgery, the levels of pain, IL-1, and BGP were measured. TWO WEEKS POST-SURGERY: On the Numerical Rating Scale, the experimental group fared better than the control group. At all three evaluation periods (1, 2, and 4 weeks postsurgery), the control group had higher BGP levels and lower IL-1 levels, whereas patients who received osteopeptide injections had higher BGP levels and statistically significant differences (P < 0.05) in both. CONCLUSIONS: After getting osteopeptide injections as an adjuvant therapy for condylar fractures, patients may have less discomfort and begin exercising their muscles more quickly. Another advantage of lowering inflammatory markers and boosting active osteogenesis is faster wound healing.